Randomised phase II study of BMS-275291 versus placebo in patients (pts) with stage IIIb or IV non small cell lung cancer (NSCLC) receiving paclitaxel + carboplatin (PC): National Cancer Institute of Canada clinical trials group (NCIC CTG) br.18 Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Douillard, J
  • Petersen, V
  • Shepherd, F
  • Paz-Ares, L
  • Arnold, Andrew
  • Tonato, M
  • Ottaway, J
  • Davis, M
  • Van Vreckem, A
  • Humphrey, J
  • Seymour, L

publication date

  • April 2001